Robert Davidson is CURE’s CEO and Chairman of the Board of
Directors. Prior to his role at CURE Pharmaceutical, Robert
Davidson served as President and Chief Executive Officer of InnoZen Inc.,
Chief Executive Officer of Gel Tech LLC, Chief Executive Officer of Bio
Delivery Technologies Inc., and has served on multiple corporate boards.
Mr. Davidson was responsible for the development of several drug delivery
technologies and commercial brand extensions. He has worked with
brands such as Chloraseptic™, Suppress™, as well as Pediastrip™, a
private label electrolyte oral thin film sold in major drug store chains.
Mr. Davidson received his B.S. degree with a concentration in Biological Life
Sciences. He has a Masters Certificate in Applied Project Management
from Villanova University, Masters of Public Health from American Military
University, Virginia and a Masters in Health and Wellness from Liberty
University, Virginia. Davidson also completed his Post Graduate Studies at the
University of Cambridge with letter of commendation.